Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

China Aesthetics Company Completes $30 Million US IPO

publication date: Oct 28, 2019

Aesthetic Medical International Holdings, a Shenzhen aesthetics company, completed a $30 million IPO on NASDAQ. AIH, also known as “Peng’ai” in China, is the third largest aesthetics service company by revenue in China, with 15 facilities in large China cities plus Hong Kong and Singapore. The IPO values AIH at $280 million. Founded over 20 years ago, AIH is more than 50% owned by Dr. Zhou Pengwu, CEO, and his wife. The ADSs, which were priced at $12 each, fell 16% to $10.03 in their first trading session. More details....

Stock Symbol: (NSDQ: AIH)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.